Contraindicated (1)bortezomib will improve the amount or influence of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Strong or moderate CYP2C19 inhibitors could raise mavacamten systemic publicity, causing heart failure on account of systolic dysfunction. The sq. root of two would be the frequency ratio of the tritone interval in https://pf-0522130487643.blog2learn.com/74886324/5-easy-facts-about-thromboxane-b2-described